Product Pipeline
Pre-Clinical > Phase I > Phase II > Phase III > Regulatory Review > Approved > Market
MOB-015
Nail Fungus
Exclusive Canadian Licence Rights
MORE DETAILS
CF-101
Moderate to severe plaque psoriasis
Exclusive Canadian Licence Rights
MORE DETAILS
DTR-001
Tattoo removal
Global Product Rights
MORE DETAILS

